FindTrial
Sign In

Homoeopathic medicines for high blood sugar in adults

A series of n-of-1 trials exploring the efficacy of individualized homeopathic medicines in LM potencies along with standard of care on glycemic control in type 2 diabetes mellitus in adults. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093949
Enrollment
21
Registered
2025-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

Intervention1: Individualized Homoeopathic Medicine plus Standard of Care with concomitant care: Intervention is planned as administering individualized homeopathic medicines in 50 millesimal potencie
14 doses to be marked on the vial( organon 6th edition paragraph 248)
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases suffering from type 2 DM (ICD 10 code E11) for more than equals to 1 year (as per ADA criteria) PPG (postprandial plasma glucose) more than equals to 200 mg/dl. HbA1c percent more than equals to 6.5 (ADA criteria) at screening and less than 10.5. Adults- men or women or transgender with T2DM BMI more than 23 and less than 45 kg/m2. Patient on stable conventional screening, anti - diabetic therapy (oral diabetic agents) for more than 3months.

Exclusion criteria

Exclusion criteria: Excessive blood glucose, FBS more than 300 mg/dl, PPBS more than 450 mg/dl Participants with type I DM or secondary diabetes (e.g., pancreatic or steroid-induced) Diagnosed cases of unstable psychiatric illness or other uncontrolled or life threatening illness affecting the quality of life or any organ failure (eg: severe liver or kidney disease, serum creatinine more than 1.4mg/dl in women and more than 1.5mg/dl in men) women of pregnancy, puerperium, lactation. Homeopathic treatment for any chronic disease within last 6 months uncontrolled HTN or severe Dyslipidaemia or diabetic and taking insulin for 6 consecutive days within the prior year Vulnerable population ? unconscious, non - ambulatory, too sick for consultation, differently abled, terminally ill or critically ill, mentally incompetent people. Tobacco, alcohol, or any kind of substance abuse and/or dependence participation in another clinical trails Self-reported immune-compromised state.

Design outcomes

Primary

MeasureTime frame
Postprandial Plasma Glucose (PPG)Timepoint: At Baseline every 17 days upto 4 months—

Secondary

MeasureTime frame
Modified Diabetes Quality of Life ? 17 questionnaire, (MDQoL-17)Timepoint: At Baseline Every 17 days upto 4 months;HbA1cTimepoint: at Baseline and after 3 months;lipid profile (LDL, HDL and their ratio)Timepoint: At baseline Every 17 days upto 4 months;Microalbumin(urine)Timepoint: At Baseline Every 17 days upto 4 months—

Countries

India

Contacts

Public ContactSHUBHAMOY GHOSH

D.N.DE HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

rithikapadhi853@gmail.com9875310854

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026